US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

308.33

-8.8700-2.80%

Post-market: 308.600.2700+0.09%19:30 EDT

Volume:354.77K

Turnover:107.70M

Market Cap:655.04M

PE:- -

High:315.40

Open:314.79

Low:293.00

Close:317.20

52wk High:341.93

52wk Low:66.60

Shares:2.12M

Float Shares:2.12M

Volume Ratio:0.70

T/O Rate:16.70%

Dividend:1.02

Dividend Rate:0.33%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

National Healthcare Declares Quarterly Dividend, Signals Ongoing Stability

Matt Phipps Initiates Buy on Upstream Bio, Citing Favorable FDA Progress and Best-in-Class Potential for Verekitug

Analysts Offer Insights on Healthcare Companies: Autolus Therapeutics (AUTL) and Cronos Group (CRON)

Analyst David Kwan Reiterates Buy on HEALWELL AI, Citing Strong Healthcare AI Positioning, Margin Expansion, and SpaceX Stake Monetization Upside

DRI Healthcare (DHT.UN) Gets a Buy from CIBC

Analysts Offer Insights on Healthcare Companies: Relmada Therapeutics (RLMD), Surgery Partners (SGRY) and Apogee Therapeutics (APGE)

Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), Legend Biotech (LEGN) and Sagimet Biosciences, Inc. Class A (SGMT)

J.P. Morgan Remains a Buy on Fortis Healthcare Ltd. (FORTIS)

Achieve Maintains Strong Cash Position and Clear FDA Path; Brandon Folkes Reiterates Buy Rating and Unchanged $12 Price Target

Analyst Maintains Buy on NGN-401 After Strong Rett Data and Cleared Safety Window, Trims Price Target to $63

Sector Update: Healthcare

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Neurosense Therapeutics Ltd. (NRSN) and Brookdale Senior Living (BKD)

Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Axsome Therapeutics (AXSM) and BridgeBio Pharma (BBIO)

Analysts Conflicted on These Healthcare Names: Rocket Pharmaceuticals (RCKT), Sonida Senior Living (SNDA) and TELA Bio (TELA)

Datasea granted FDA registration and listing for NeuroVibe Acoustic BCI system

Analysts Conflicted on These Healthcare Names: GE Healthcare Technologies Inc (GEHC), Vertex Pharmaceuticals (VRTX) and Agios Pharma (AGIO)

Intelligent Bio Solutions Announces Completion of Method Comparison Study for the Intelligent Fingerprinting Drug Screening System

Achieve Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Updates

Analysts’ Top Healthcare Picks: Qiagen (QGEN), Establishment Labs Holdings (ESTA)

DRI Healthcare Trust Collects $178M for Ekterly Royalty Exit

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/LABU/news?page=19"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":308.33,"timestamp":1787601600000,"preClose":317.2,"halted":0,"volume":354768,"hourTrading":{"tag":"盘后","latestPrice":308.6,"preClose":308.33,"latestTime":"19:30 EDT","volume":551,"amount":170104.25165000002,"timestamp":1787614206454,"change":0.27,"changeRate":0.000876,"amplitude":0.014724},"delay":0,"changeRate":-0.027963430012610355,"floatShares":2124486,"shares":2124486,"eps":0,"marketStatus":"Post-Mkt","change":-8.87,"latestTime":"08-24 19:35:36 EDT","open":314.79,"high":315.4,"low":293,"amount":107704850.8248,"amplitude":0.070618,"askPrice":310.79,"askSize":53,"bidPrice":308,"bidSize":20,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787616000000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":317.2,"sharesOutstanding":3074486,"nav":316.946,"aum":673347221.03,"dividendRate":0.003292,"bidAskSpread":0.002803,"preHourTrading":{"tag":"盘前","latestPrice":314.59,"preClose":317.2,"latestTime":"09:25 EDT","volume":1055,"amount":335012.8868,"timestamp":1787577900633,"change":-2.61,"changeRate":-0.008228,"amplitude":0.020255},"postHourTrading":{"tag":"盘后","latestPrice":308.6,"preClose":308.33,"latestTime":"19:30 EDT","volume":551,"amount":170104.25165000002,"timestamp":1787614206454,"change":0.27,"changeRate":0.000876,"amplitude":0.014724},"volumeRatio":0.700668,"impliedVol":0.977,"impliedVolPercentile":0.757},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2124486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.700668,"shares":2124486,"dividePrice":1.015,"high":315.4,"amplitude":0.070618,"preClose":317.2,"low":293,"week52Low":66.6,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":308.33,"committee":-0.452055,"eps":0,"divideRate":0.003292,"volume":354768,"delay":0,"ttmEps":0,"open":314.79,"prevYearClose":159.39,"prevWeekClose":317.2,"prevMonthClose":227.4,"prevQuarterClose":292.1,"fiveDayClose":287.3,"twentyDayClose":246.27,"sixtyDayClose":191.66},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:19,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658910278","title":"National Healthcare Declares Quarterly Dividend, Signals Ongoing Stability","url":"https://stock-news.laohu8.com/highlight/detail?id=2658910278","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658910278?lang=en_us&edition=fundamental","pubTime":"2026-08-12 03:18","pubTimestamp":1786475918,"startTime":"0","endTime":"0","summary":"National Healthcare ( ($NHC) ) has issued an update. On August 6, 2026, National HealthCare Corporation announced it will pay a quarterly cash divi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/national-healthcare-declares-quarterly-dividend-signals-ongoing-stability?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/national-healthcare-declares-quarterly-dividend-signals-ongoing-stability?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","XLV","BK4581","BK4585","BK4588","XBI","BK4185","NHC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658221910","title":"Matt Phipps Initiates Buy on Upstream Bio, Citing Favorable FDA Progress and Best-in-Class Potential for Verekitug","url":"https://stock-news.laohu8.com/highlight/detail?id=2658221910","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658221910?lang=en_us&edition=fundamental","pubTime":"2026-08-12 03:05","pubTimestamp":1786475121,"startTime":"0","endTime":"0","summary":"William Blair analyst Matt Phipps has maintained their bullish stance on UPB stock, giving a Buy rating today. Matt Phipps has given his Buy rating...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/matt-phipps-initiates-buy-on-upstream-bio-citing-favorable-fda-progress-and-best-in-class-potential-for-verekitug-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/matt-phipps-initiates-buy-on-upstream-bio-citing-favorable-fda-progress-and-best-in-class-potential-for-verekitug-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4097","BK4588","BK4139","LU2065732104.USD","UPB","PRGS","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658910604","title":"Analysts Offer Insights on Healthcare Companies: Autolus Therapeutics (AUTL) and Cronos Group (CRON)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658910604","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658910604?lang=en_us&edition=fundamental","pubTime":"2026-08-12 03:00","pubTimestamp":1786474815,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Autolus Therapeutics (AUTL) and Cronos Group (CRON) ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-autolus-therapeutics-autl-and-cronos-group-cron-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-autolus-therapeutics-autl-and-cronos-group-cron-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MJ","BK4588","BK4137","LU0128526141.USD","HCSG","YOLO","XLV","CRON","LABU","LU0029874061.USD","BK4581","BK4007","AUTL","BK4585","BK4557","XBI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658991062","title":"Analyst David Kwan Reiterates Buy on HEALWELL AI, Citing Strong Healthcare AI Positioning, Margin Expansion, and SpaceX Stake Monetization Upside","url":"https://stock-news.laohu8.com/highlight/detail?id=2658991062","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658991062?lang=en_us&edition=fundamental","pubTime":"2026-08-12 02:55","pubTimestamp":1786474544,"startTime":"0","endTime":"0","summary":"HEALWELL AI, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst David Kwan from TD Cowen maintained a Buy rat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-david-kwan-reiterates-buy-on-healwell-ai-citing-strong-healthcare-ai-positioning-margin-expansion-and-spacex-stake-monetization-upside-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-david-kwan-reiterates-buy-on-healwell-ai-citing-strong-healthcare-ai-positioning-margin-expansion-and-spacex-stake-monetization-upside-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ELOL","MARS","WSPC","LU2290526834.HKD","LOFF","UFO","BK4588","DXYZ","QTOC","WARP","SPCX","SPAL","XLV","SPCH","SPCG","BK4089","SPCM","AIPO","ORBX","HAIAU","CHAT","VTHR","BK4615","LU1861558580.USD","BK4581","SPAX","SNK","BK4585","AGIX","LU1861220033.SGD","XOVR","SPCU","LU2360107168.USD","SPCQ","SSPC","LU1861559042.SGD","XBI","LU1861215975.USD","ARTY","LOFD","LABU","SPCF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658910886","title":"DRI Healthcare (DHT.UN) Gets a Buy from CIBC","url":"https://stock-news.laohu8.com/highlight/detail?id=2658910886","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658910886?lang=en_us&edition=fundamental","pubTime":"2026-08-12 02:36","pubTimestamp":1786473381,"startTime":"0","endTime":"0","summary":"CIBC analyst Erin Kyle maintained a Buy rating on DRI Healthcare today and set a price target of C$21.00. Kyle covers the Technology sector, focusi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/dri-healthcare-dht-un-gets-a-buy-from-cibc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/dri-healthcare-dht-un-gets-a-buy-from-cibc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4209","BK4581","BK4588","LU0029874061.USD","TECS","XLV","HCSG","BK4137","LU0154245756.USD","LU0154245673.USD","DRI","LU0128526141.USD","BK4585","LABU","XBI","BK4504","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658433917","title":"Analysts Offer Insights on Healthcare Companies: Relmada Therapeutics (RLMD), Surgery Partners (SGRY) and Apogee Therapeutics (APGE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658433917","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658433917?lang=en_us&edition=fundamental","pubTime":"2026-08-12 02:10","pubTimestamp":1786471809,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Relmada Therapeutics (RLMD), Surgery Partners (SGRY) and Apogee T...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-relmada-therapeutics-rlmd-surgery-partners-sgry-and-apogee-therapeutics-apge-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-relmada-therapeutics-rlmd-surgery-partners-sgry-and-apogee-therapeutics-apge-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APGE","LU0128526141.USD","BK4588","HCSG","BK4139","SBIO","XLV","BK4581","PSIL","BK4585","LU0053671581.USD","SGRY","LU0029874061.USD","LABU","XBI","BK4137","BK4007","RLMD","BK4185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658791274","title":"Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), Legend Biotech (LEGN) and Sagimet Biosciences, Inc. Class A (SGMT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658791274","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658791274?lang=en_us&edition=fundamental","pubTime":"2026-08-12 01:40","pubTimestamp":1786470008,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Immunic (IMUX), Legend Biotech (LEGN) and Sagimet Bi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-immunic-imux-legend-biotech-legn-and-sagimet-biosciences-inc-class-a-sgmt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-immunic-imux-legend-biotech-legn-and-sagimet-biosciences-inc-class-a-sgmt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","XBI","CANC","HCSG","BK4585","IMUX","LEGN","MEDI","MEMS","XLV","LABU","BK4581","BK4139","BK4505","BK4137","LU0029874061.USD","SGMT","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658912744","title":"J.P. Morgan Remains a Buy on Fortis Healthcare Ltd. (FORTIS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658912744","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658912744?lang=en_us&edition=fundamental","pubTime":"2026-08-12 01:35","pubTimestamp":1786469755,"startTime":"0","endTime":"0","summary":"J.P. Morgan analyst Bansi Desai maintained a Buy rating on Fortis Healthcare Ltd. yesterday and set a price target of INR1,180.00. The company’s sh...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/j-p-morgan-remains-a-buy-on-fortis-healthcare-ltd-fortis-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/j-p-morgan-remains-a-buy-on-fortis-healthcare-ltd-fortis-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IAI","LABU","LU0106831901.USD","BK4534","LU0971096721.USD","LU1244550577.SGD","LU0528227936.USD","LU1989772923.USD","LU1162221912.USD","IE00B775SV38.USD","LU2347655156.SGD","LU2487616109.SGD","LU0390134368.USD","IE00BKVL7J92.USD","LU1363072403.SGD","XBI","LU2133065610.SGD","LU0912757837.SGD","LU2089283258.USD","LU0158827781.USD","BK4516","LU0795875169.SGD","LU0029874061.USD","IE00BZ1G4Q59.USD","LU1989772840.SGD","LU0006306889.USD","LU1732800096.USD","HCSG","LU1074936037.SGD","LU2271345857.HKD","LU0158827948.USD","BK4137","BK4585","LU1548497426.USD","LU0225283273.USD","LU1720051108.HKD","LU0234570918.USD","LU2023251221.USD","KBWB","LU0210528500.USD","XLV","LU0106261372.USD","LU0882574139.USD","LU1720051017.SGD","IE00B3S45H60.SGD","LU0320765646.SGD","LU2111349929.HKD","LU1791710582.SGD","LU1668664300.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658912719","title":"Achieve Maintains Strong Cash Position and Clear FDA Path; Brandon Folkes Reiterates Buy Rating and Unchanged $12 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2658912719","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658912719?lang=en_us&edition=fundamental","pubTime":"2026-08-12 01:35","pubTimestamp":1786469751,"startTime":"0","endTime":"0","summary":"Analyst Brandon Folkes of H.C. Wainwright reiterated a Buy rating on Achieve Life Sciences, retaining the price target of $12.00. Brandon Folkes ha...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/achieve-maintains-strong-cash-position-and-clear-fda-path-brandon-folkes-reiterates-buy-rating-and-unchanged-12-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/achieve-maintains-strong-cash-position-and-clear-fda-path-brandon-folkes-reiterates-buy-rating-and-unchanged-12-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658291273","title":"Analyst Maintains Buy on NGN-401 After Strong Rett Data and Cleared Safety Window, Trims Price Target to $63","url":"https://stock-news.laohu8.com/highlight/detail?id=2658291273","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658291273?lang=en_us&edition=fundamental","pubTime":"2026-08-12 01:35","pubTimestamp":1786469744,"startTime":"0","endTime":"0","summary":"Neurogene, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Patrick Dolezal from LifeSci Capital maintained a B...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-maintains-buy-on-ngn-401-after-strong-rett-data-and-cleared-safety-window-trims-price-target-to-63-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-maintains-buy-on-ngn-401-after-strong-rett-data-and-cleared-safety-window-trims-price-target-to-63-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LABU","XBI","BK4588","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658644912","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2658644912","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658644912?lang=en_us&edition=fundamental","pubTime":"2026-08-12 01:15","pubTimestamp":1786468518,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined Tuesday afternoon, with the NYSE Healthcare Index shedding 0.6% and the State Street Health Care Select Sector SPDR ETF  decreasing 0.4%.The iShares Biotechnology ETF  rose 0.3%In corporate news, Hims & Hers Health  shares were down 3.8% following its Q2 results. The results were mixed, with upside in its US business from branded GLP-1 strength and a ramp in testosterone offset by disappointing gross margin and weak free cash flow, Morgan Stanley said in a note.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1074936037.SGD","LU0158827781.USD","LU0390134368.USD","LU1732799900.SGD","LU1668664300.SGD","LU1989772923.USD","KBWB","LU2089283258.USD","HEAL","LU2089284900.SGD","LU2271345857.HKD","LU0053666078.USD","LU0106831901.USD","LU0267386448.USD","LU0528227936.USD","GLAM","HIMS","LU2028103732.USD","HIYY","LU1791710400.SGD","LU0971096721.USD","BK4504","LU2023251221.USD","LU1732800096.USD","LU1791710582.SGD","THNR","LU0210528500.USD","BK4585","BK4588","IE00BZ1G4Q59.USD","XBI","LU0098860793.USD","LU0320765646.SGD","LU2264538146.SGD","IBB","LU1162221912.USD","LU2357305700.SGD","IE00B3S45H60.SGD","IAI","BK4516","LU2133065610.SGD","LU0225283273.USD","XLV","LU1064131342.USD","IE00BKVL7J92.USD","LU0314104364.USD","BK4534","BK4127","HMYY","LU1720051108.HKD","BK4196","LU0557290698.USD","LU0795875086.SGD","LU0106261372.USD","LU0882574139.USD","BK4581","LU0006306889.USD","LU2347655156.SGD","LU1244550221.USD","HIMZ","HIMY","LU1363072403.SGD","LU2487616109.SGD","LABU","MS","LU2111349929.HKD","LU0795875169.SGD","LU0234570918.USD","IE00B775SV38.USD","LU1244550494.USD","LU0912757837.SGD","LU1988902786.USD","LU1720051017.SGD","LU0158827948.USD","LU1244550577.SGD","LU1548497426.USD","LU1989772840.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658911286","title":"Analysts Offer Insights on Healthcare Companies: Neurosense Therapeutics Ltd. (NRSN) and Brookdale Senior Living (BKD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658911286","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658911286?lang=en_us&edition=fundamental","pubTime":"2026-08-11 23:40","pubTimestamp":1786462847,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Neurosense Therapeutics Ltd. (NRSN) and Brookdale Se...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-neurosense-therapeutics-ltd-nrsn-and-brookdale-senior-living-bkd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-neurosense-therapeutics-ltd-nrsn-and-brookdale-senior-living-bkd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2190626999.HKD","BK4581","BK4137","BK4185","HCSG","LU0128526141.USD","LU0842063009.USD","BKD","LU1499592464.USD","NRSN","XBI","BK4585","XLV","BK4588","LU0029874061.USD","BK4139","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658064919","title":"Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Axsome Therapeutics (AXSM) and BridgeBio Pharma (BBIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658064919","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658064919?lang=en_us&edition=fundamental","pubTime":"2026-08-11 23:00","pubTimestamp":1786460418,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Cardinal Health (CAH), Axsome Therapeutics (AXSM) an...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-cardinal-health-cah-axsome-therapeutics-axsm-and-bridgebio-pharma-bbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-cardinal-health-cah-axsome-therapeutics-axsm-and-bridgebio-pharma-bbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1880398554.USD","BK4007","LU0310800965.SGD","XBI","LU0029874061.USD","LU0154236417.USD","HCSG","LU0211328371.USD","SG9999001440.SGD","BK4139","LU1983299246.USD","AXSM","BK4581","LU0211327993.USD","LU2324357040.USD","LU0128526141.USD","LU0128525689.USD","LU0310799852.SGD","BK4585","BK4588","LU1267930490.SGD","LU0006061336.USD","BBIO","BK4137","LU0162691827.USD","LABU","BK4505","XLV","CAH","LU0889566641.SGD","LU0072461881.USD","LU1571399168.USD","LU1267930813.SGD","LU0052756011.USD","BK4175","LU0792757196.USD","LU1880398471.USD","LU1267930227.SGD","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658916594","title":"Analysts Conflicted on These Healthcare Names: Rocket Pharmaceuticals (RCKT), Sonida Senior Living (SNDA) and TELA Bio (TELA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658916594","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658916594?lang=en_us&edition=fundamental","pubTime":"2026-08-11 21:50","pubTimestamp":1786456215,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Rocket Pharmaceuticals (RCKT), Sonida Senior Living (SNDA) and TE...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-rocket-pharmaceuticals-rckt-sonida-senior-living-snda-and-tela-bio-tela-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-rocket-pharmaceuticals-rckt-sonida-senior-living-snda-and-tela-bio-tela-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4198","BK4581","BK4137","BK4185","HCSG","LU0128526141.USD","SNDA","XBI","RCKT","TELA","BK4585","XLV","BK4588","LU0029874061.USD","BK4139","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658833915","title":"Datasea granted FDA registration and listing for NeuroVibe Acoustic BCI system","url":"https://stock-news.laohu8.com/highlight/detail?id=2658833915","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658833915?lang=en_us&edition=fundamental","pubTime":"2026-08-11 21:11","pubTimestamp":1786453883,"startTime":"0","endTime":"0","summary":"Datasea’s (DTSS) variable interest entity in China, Shuhai Jingwei, has completed establishment registration and device listing with the FDA for it...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/datasea-granted-fda-registration-and-listing-for-neurovibe-acoustic-bci-system-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/datasea-granted-fda-registration-and-listing-for-neurovibe-acoustic-bci-system-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4563","BABO","BCI","BK4585","BBYY","DRAG","BK4588","KBAB","KCAI","BABW","BABU","DTSS","MAGC","BABX","BK4097","LABU","KPRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658913504","title":"Analysts Conflicted on These Healthcare Names: GE Healthcare Technologies Inc (GEHC), Vertex Pharmaceuticals (VRTX) and Agios Pharma (AGIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658913504","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658913504?lang=en_us&edition=fundamental","pubTime":"2026-08-11 21:00","pubTimestamp":1786453226,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on GE Healthcare Technologies Inc (GEHC), Vertex Pharmaceuticals (VR...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-ge-healthcare-technologies-inc-gehc-vertex-pharmaceuticals-vrtx-and-agios-pharma-agio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-ge-healthcare-technologies-inc-gehc-vertex-pharmaceuticals-vrtx-and-agios-pharma-agio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0002270589.USD","LU1261432733.SGD","LU2756315664.SGD","BK4532","GE","GNMX","EXI","TBXU","LU0417517546.SGD","PPA","LU0058720904.USD","LU1559883803.SGD","LU2417539215.USD","LU0757428866.USD","BIB","LU0157215616.USD","XLV","XBI","METV","NATO","MISL","BBH","PBE","LU2756315318.SGD","TRUI","IBBQ","AGIO","IE0009355771.USD","LU2089984988.USD","BK4588","ITA","LU1093756325.SGD","UXI","IE00B19Z9P08.USD","LGHT","LU0267386448.USD","GEHC","XAR","LU0353189680.USD","SG9999001176.SGD","VERX","VRTX","BK4139","IBB","DFEN","IDNA","LU1084165304.USD","LU0820561909.HKD","LABU","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658918194","title":"Intelligent Bio Solutions Announces Completion of Method Comparison Study for the Intelligent Fingerprinting Drug Screening System","url":"https://stock-news.laohu8.com/highlight/detail?id=2658918194","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658918194?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:30","pubTimestamp":1786451400,"startTime":"0","endTime":"0","summary":"All clinical data collection across the Company's FDA 510(k) clinical study program is complete; FDA submission on track for second half of 2026NEW YORK, Aug.  11, 2026  (GLOBE NEWSWIRE) -- Intelligen","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/11/3342694/0/en/intelligent-bio-solutions-announces-completion-of-method-comparison-study-for-the-intelligent-fingerprinting-drug-screening-system.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658118918","title":"Achieve Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2658118918","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658118918?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:30","pubTimestamp":1786451400,"startTime":"0","endTime":"0","summary":"Closed a private placement of up to $354 million, with $180 million upfront and up to $174 million from warrants exercisable prior to and up to 20 trading days following FDA approval Strengthened orga","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/11/3342705/0/en/achieve-life-sciences-reports-second-quarter-2026-financial-results-and-provides-business-updates.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0390134368.USD","ATS","BK4121","BK4161","IEIH","IE00BFMHRM44.USD","LU0029874061.USD","BK4530","LU0128526141.USD","LABU","LU0757428866.USD","BK4588","BK4585","LU1815336091.USD","CRL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658899073","title":"Analysts’ Top Healthcare Picks: Qiagen (QGEN), Establishment Labs Holdings (ESTA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658899073","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658899073?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:20","pubTimestamp":1786450836,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Qiagen (QGEN) and Establishment Labs Holdings (ESTA)...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-qiagen-qgen-establishment-labs-holdings-esta-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-qiagen-qgen-establishment-labs-holdings-esta-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4198","BK4121","HCSG","LU1923622614.USD","LU2433249047.HKD","BK4588","LU0128526141.USD","ESTA","XBI","BK4137","LABU","QGEN","LU2324357040.USD","LU2125909593.SGD","XLV","BK4581","BK4585","LU0029874061.USD","LU2125909247.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658990417","title":"DRI Healthcare Trust Collects $178M for Ekterly Royalty Exit","url":"https://stock-news.laohu8.com/highlight/detail?id=2658990417","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658990417?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:19","pubTimestamp":1786450740,"startTime":"0","endTime":"0","summary":"DRI Healthcare Trust has cashed out of its royalty investment in the drug Ekterly, collecting about $178 million.The Toronto-based healthcare fund on Tuesday said it exercised a contractual option to sell back its royalty rights following Chiesi Group's takeover of KalVista Pharmaceuticals, the developer of Ekterly.In June, Italian pharmaceutical firm Chiesi Group acquired KalVista Pharmaceuticals, the developer of Ekterly, an oral medication developed for hereditary angioedema, for about $1.9 billion.The takeover triggered a contractual put option clause, giving DRI Healthcare the right to compel the buyer to repurchase its royalty stake rather than continuing to hold the long-term royalty stream.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4504","BK4209","HCSG","LABU","BK4588","LU0154245673.USD","BK4137","BK4585","XBI","LU0128526141.USD","BK4581","DRI","LU0029874061.USD","LU0154245756.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":19,"totalSize":398,"code":"91000000","status":"200"}]}}